Clinical Study
Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas
Table 2
Patients characteristics of HL with very late relapse.
| | Time to relapse | AGE at DG | Sex | Histol. | First-Line regimen | Lymphoma localization | Therapy | Responce | Second relapse | Cause of death | OS | FFS |
| | | | | | | at diagnosis | at relapse | at relapse | | | | mths | mths | | 1 | 5 | 46 | F | NS | MOPP/ABVD | INFRA | SUPRA | MOPP/ABVD | CR | YES | GRAM- sepsis | 55 | 17 | | 2 | 5 | 23 | F | MC | MOPP/ABVD | INFRA | SUPRA | MOPP/ABVD | CR | NO | | 250 | 250 | | 3 | 5 | 70 | M | NS | MOPP + I.F.Radioth. | SUPRA | SUPRA | MOPP/ABVD | PR | | Disease progr. | 16 | 16 | | 4 | 8 | 20 | F | NS | HDS-ASCT + I.F.Radioth. | INFRA + SUPRA | INFRA | BEACOPP | CR | NO | | 32 | 32 | | 5 | 18 | 37 | F | NS | MOPP + I.F.Radioth. | SUPRA | INFRA | ABVD | CR | NO | | 32 | 32 | | 6 | 8 | 20 | F | MC | MOPP/ABVD + I.F.Radioth. | SUPRA | INFRA + SUPRA | ABVD | CR | NO | | 233 | 233 | | 7 | 5 | 16 | F | NS | MOPP | INFRA + SUPRA | INFRA | ABVD | CR | YES | | 148 | 124 | | 8 | 5 | 66 | F | MC | MOPP + I.F.Radioth. | SUPRA | INFRA | ABVD | CR | NO | | 47 | 47 | | 9 | 5 | 56 | F | MC | MOPP/ABVD | SUPRA | INFRA | MOPP/ABVD | CR | NO | Tromboembolic D. | 8 | 8 | | 10 | 11 | 32 | F | NS | MOPP + I.F.Radioth. | SUPRA | SUPRA | ABVD | CR | YES | GRAM- sepsis | 21 | 21 | | 11 | 10 | 22 | F | MC | HDS-ASCT + I.F.Radioth. | INFRA + SUPRA | INFRA | BEACOPP | CR | NO | | 8 | 8 | | 12 | 9 | 68 | M | MC | I.F.Radioth. | SUPRA | INFRA | VEPEM-B | CR | NO | | 45 | 45 | | 13 | 6 | 52 | M | MC | MOPP | INFRA + SUPRA | SUPRA | ABVD | CR | NO | HCV reactivation | 29 | 29 | | 14 | 7 | 35 | M | NS | MOPP/ABVD + I.F.Radioth. | INFRA + SUPRA | INFRA | MOPP/ABVD | CR | YES | cardiac failure | 50 | 30 | | 15 | 7 | 18 | M | NS | MOPP/ABVD + I.F.Radioth. | INFRA + SUPRA | INFRA + SUPRA | ABVD | PR | | | 26 | 26 | | 16 | 5 | 18 | M | NS | ABVD + I.F.Radioth. | SUPRA | SUPRA | IGEV-ASCT | CR | NO | | 12 | 12 |
|
|
